Our projects include a wide range of pharmacoeconomic studies, such as CMA, CEA, CBA, CUA, and research-based QALY/DALY calculations.

We offer math-based dynamic Gross-to-Net (GtN) calculations for a whole chain - from gross sales, rebates, chargebacks, vouchers, returns, discounts, wholesale fees to net sales.

We build an accurate market math-model which clearly reflects probabilistic processes, technology’s life-cycle, long- and short-term behavior of the market.

We provide regulatory support and policy advocacy for our research, as well as legal advisory in health, pharm and life science.